HANATOUR JAPAN CO.,LTD. Logo

HANATOUR JAPAN CO.,LTD.

B2C/B2B travel firm providing packages, MICE, and inbound services, with a focus on Korea.

6561 | T

Overview

Corporate Details

ISIN(s):
JP3769900006
LEI:
Country:
Japan
Address:
港区虎ノ門五丁目12番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HANATOUR JAPAN CO.,LTD. is an integrated travel company that provides a wide range of domestic and international travel services. The company operates in both business-to-consumer (B2C) and business-to-business (B2B) markets. Its core offerings include the design and execution of diverse travel packages, hotel booking, and ticketing. HANATOUR JAPAN specializes in various segments, including leisure holidays, educational tours, and corporate incentive travel, with a particular focus on Meetings, Incentives, Conferences, and Exhibitions (MICE). A key area of its business is managing inbound travel services, especially from South Korea. For its B2B partners, the company provides travel business solutions to help travel agents customize tours and enhance sales.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 09:01
Interim Report
確認書
Japanese 9.2 KB
2025-08-14 09:00
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 225.1 KB
2025-03-31 06:22
Regulatory News Service
臨時報告書
Japanese 26.9 KB
2025-03-28 08:03
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.6 KB
2025-03-28 08:03
Registration Form
確認書
Japanese 8.8 KB
2025-03-28 08:02
Registration Form
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.0 MB
2024-08-14 09:32
Regulatory News Service
確認書
Japanese 8.9 KB
2024-08-14 09:31
Interim Report
半期報告書-第20期(2024/01/01-2024/12/31)
Japanese 215.0 KB
2024-05-14 09:07
Regulatory News Service
確認書
Japanese 8.9 KB
2024-05-14 09:06
Quarterly Report
四半期報告書-第20期第1四半期(2024/01/01-2024/03/31)
Japanese 182.2 KB
2024-03-29 03:31
Post-Annual General Meeting Information
臨時報告書
Japanese 21.1 KB
2024-03-28 08:04
Regulatory News Service
確認書
Japanese 9.0 KB
2024-03-28 08:03
Regulatory News Service
内部統制報告書-第19期(2023/01/01-2023/12/31)
Japanese 24.0 KB
2024-03-28 08:01
Annual Report
有価証券報告書-第19期(2023/01/01-2023/12/31)
Japanese 1.0 MB
2023-11-14 08:04
Report Publication Announcement
確認書
Japanese 8.9 KB

Automate Your Workflow. Get a real-time feed of all HANATOUR JAPAN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HANATOUR JAPAN CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HANATOUR JAPAN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mare Nostrum Logo
Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.
France ALMAR
Marubeni Construction Material Lease Co.,Ltd. Logo
Leases and sells temporary steel materials and offers engineering for major construction projects.
Japan 9763
MATCHING SERVICE JAPAN CO.,LTD. Logo
Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.
Japan 6539
Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan 156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland MDB
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea 235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan 4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan 7369

Talk to a Data Expert

Have a question? We'll get back to you promptly.